{
    "organizations": [],
    "uuid": "b93fe93bfa19f9824005529070c2e5ee58d8de55",
    "author": "",
    "url": "https://www.reuters.com/article/brief-aralez-pharmaceuticals-reports-q1/brief-aralez-pharmaceuticals-reports-q1-loss-per-share-of-0-29-idUSASC0A0DK",
    "ord_in_thread": 0,
    "title": "BRIEF-Aralez Pharmaceuticals Reports Q1 Loss Per Share Of $0.29",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 8, 2018 / 11:05 AM / in 3 minutes BRIEF-Aralez Pharmaceuticals Reports Q1 Loss Per Share Of $0.29 Reuters Staff\nMay 8 (Reuters) - Aralez Pharmaceuticals Inc: * ARALEZ ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS\n* 1Q 2018 NET REVENUES INCREASED TO $38.1 MILLION VERSUS $26.0 MILLION IN 1Q 2017 * WITHDRAWING ITS PREVIOUS GUIDANCE\n* AS OF MARCH 31, 2018 HAD CASH AND CASH EQUIVALENTS OF APPROXIMATELY $43.9 MILLION\n* ARALEZ - DETERMINED THERE IS REASONABLE POSSIBILITY CO WILL NOT HAVE SUFFICIENT LIQUIDITY TO FUND CURRENT & PLANNED OPERATIONS THROUGH NEXT 12 MONTHS\n* ARALEZ PHARMACEUTICALS - THERE IS SUBSTANTIAL DOUBT ABOUT COMPANYâ€™S ABILITY TO CONTINUE AS A GOING CONCERN Source text for Eikon: Further company coverage:",
    "published": "2018-05-08T14:01:00.000+03:00",
    "crawled": "2018-05-08T14:16:32.012+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "minute",
        "pharmaceutical",
        "report",
        "q1",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "may",
        "reuters",
        "aralez",
        "pharmaceutical",
        "inc",
        "aralez",
        "announces",
        "first",
        "quarter",
        "financial",
        "result",
        "1q",
        "net",
        "revenue",
        "increased",
        "million",
        "versus",
        "million",
        "1q",
        "withdrawing",
        "previous",
        "guidance",
        "march",
        "cash",
        "cash",
        "equivalent",
        "approximately",
        "million",
        "aralez",
        "determined",
        "reasonable",
        "possibility",
        "co",
        "sufficient",
        "liquidity",
        "fund",
        "current",
        "planned",
        "operation",
        "next",
        "month",
        "aralez",
        "pharmaceutical",
        "substantial",
        "doubt",
        "company",
        "ability",
        "continue",
        "going",
        "concern",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}